Travere Therapeutics logo
Travere Therapeutics TVTX
$ 18.38 0.66%

Quarterly report 2024-Q3
added 10-31-2024

report update icon

Travere Therapeutics DSO Ratio 2011-2024 | TVTX

Annual DSO Ratio Travere Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
153 203 44.1 31.3 - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
203 31.3 108

Quarterly DSO Ratio Travere Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
36 39.8 48.4 - 43 59.4 56.4 - 20.6 12.4 28.8 - 16.9 20.8 27.9 28.5 28.4 30 32.5 35.3 37.1 36.8 35.4 26.4 28.4 27.9 31.5 30 31.4 32.6 43.9 - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
59.4 12.4 33.1